ABC-04 a Phase 1B Study of Cisplatin, Gemcitabine and Selumetinib in Patients With Advanced Biliary Tract Cancer.
Phase of Trial: Phase I
Latest Information Update: 08 Jun 2016
At a glance
- Drugs Selumetinib (Primary) ; Cisplatin; Gemcitabine
- Indications Biliary cancer; Gallbladder cancer
- Focus Adverse reactions
- 10 May 2016 Status changed from active, no longer recruiting to completed.
- 26 Sep 2013 Planned end date changed from 1 Aug 2013 to 1 Jan 2015 as reported by ClinicalTrials.gov.
- 16 Mar 2013 Accrual to date is 108% according to United Kingdom Clinical Research Network.